Vacina Pneumocócica: SUS Pneumo 10 vs. Private Pneumo 13, 15 & 23
Pneumococcal vaccine guide: SUS schedule for infants (Pneumo 10) and CRIE high-risk adults (Pneumo 23), private Pneumo 13/15 coverage, and pneumonia protection.
What is the Pneumococcal Vaccine (Vacina Pneumocócica) and how does SUS coverage compare to private clinics?
Bacterial Serotypes, Conjugation Immunology, and Vaccine Differences
*Streptococcus pneumoniae* comprises over 100 distinct polysaccharide capsule serotypes, but a defined cluster of approximately 10 to 23 serotypes causes over 80% of all severe invasive pneumococcal diseases (meningitis, bacteremia, and septic pneumonia) globally.
Vaccines are divided into two immunological classes: Polysaccharide and Conjugated. The classic Pneumo 23 (VPP23) presents purified bacterial capsular polysaccharides. While it covers 23 distinct serotypes, it induces T-cell independent immunity, meaning it does not produce long-term immunological memory, does not reduce nasopharyngeal mucosal colonization (herd immunity), and is ineffective in children under 2 years of age.
To overcome these limitations, Conjugated Vaccines (Pneumo 10, 13, 15, and 20) bind bacterial polysaccharides covalently to a diphtheria carrier protein (CRM197). This triggers robust T-cell dependent immunological memory, produces sustained antibody titers, prevents mucosal bacterial carriage, and grants strong protection to infants and older adults.
SUS Availability vs. Private Network Guidelines for Adults and Seniors
Through the Programa Nacional de Imunizações (PNI), the SUS guarantees free administration of the 10-valent conjugated vaccine (Pneumo 10) to all children born in Brazil at 2 months and 4 months, concluding with a booster dose at 12 months. This public health campaign dramatically reduced pediatric meningitis and pneumonia hospitalizations nationwide.
For adults and seniors, the public system deploys the 23-valent polysaccharide vaccine (Pneumo 23) primarily through Centros de Referência para Imunobiológicos Especiais (CRIE) for individuals with high-risk clinical conditions—including chronic cardiopulmonary disease, asthma, diabetes mellitus, sickle cell disease, chronic kidney disease, solid organ transplantation, and asplenia.
In the private health network, the Sociedade Brasileira de Imunizações (SBIm) recommends an optimal combined schedule for all adults aged 60 and older: an initial dose of a conjugated vaccine (Pneumo 13 or Pneumo 15), followed 6 to 12 months later by a dose of Pneumo 23, concluded by a final Pneumo 23 booster 5 years later, maximizing serotype coverage while establishing durable immune memory.
Comprehensive Comparison: Pneumo 10 vs. Pneumo 13 vs. Pneumo 15 vs. Pneumo 23
| Vaccine Product | Immunology Class | Serotypes Covered | SUS Availability | Private Availability |
|---|---|---|---|---|
| Pneumo 10 (VPC10) | Conjugated (T-cell Memory) | 10 Serotypes (1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, 23F) | FREE at all Postos de Saúde for infants | Rare (Replaced by 13/15) |
| Pneumo 13 (VPC13) | Conjugated (T-cell Memory) | 13 Serotypes (Pneumo 10 + 3, 6A, 19A) | Restricted CRIE (High-Risk conditions) | Widely Available (~R$ 300) |
| Pneumo 15 (VPC15) | Conjugated (T-cell Memory) | 15 Serotypes (Pneumo 13 + 22F, 33F) | Not Available on Standard SUS | Widely Available (~R$ 350) |
| Pneumo 23 (VPP23) | Polysaccharide (B-cell) | 23 Broad Serotypes | FREE at CRIE for chronic illness/elderly | Widely Available (~R$ 150) |
Step-by-Step SOP to Receive Pneumococcal Vaccination in Brazil
Verify Routine Pediatric Card at Posto de Saúde
Ensure infants receive their free Pneumo 10 doses at 2, 4, and 12 months at any municipal basic health unit (UBS).
Obtain Physician Referral Letter for CRIE (Chronic Patients)
Patients with diabetes, heart disease, or respiratory illness should obtain a medical report (laudo médico) listing their ICD/CID code.
Present Documentation at Municipal CRIE Unit
Present your medical report, ID, and SUS card at an accredited CRIE center to receive free Pneumo 23 or Pneumo 13 shots.
Consult Private Clinics for Sequential Senior Schedule
Individuals aged 60+ seeking maximum protection can follow the SBIm sequential protocol (Pneumo 13/15 followed by Pneumo 23) at private clinics.
Fundamentação Legal e Fontes Oficiais
📺 Tutoriais e Análises em Vídeo Verificados
4 Vídeos SelecionadosAnálises de Especialistas e Práticos de Mercado
"Pneumococcal disease is one of the leading preventable causes of death among seniors over 65 in Brazil. Utilizing conjugate vaccines to establish T-cell memory followed by broad polysaccharide coverage represents the gold standard in adult immunization."
"Many diabetic and asthmatic patients do not realize they qualify for free Pneumo 23 at the CRIE through the SUS. A simple doctor's note detailing your diagnosis unlocks free public immunization."
Perguntas Frequentes (FAQ)
Can the pneumococcal vaccine cause pneumonia?▼
No. None of the pneumococcal vaccines contain live bacteria. They are formulated with purified non-living capsular proteins and polysaccharides. They cannot cause pneumonia, bacteremia, or meningitis under any circumstances.
What are the common side effects after vaccination?▼
Common reactions are mild and transient, including localized soreness, redness, and mild swelling at the injection site, accompanied occasionally by low-grade fever, fatigue, or muscle aches lasting 24 to 48 hours.
Can the pneumococcal vaccine be administered on the same day as the flu vaccine (gripe)?▼
Yes. Clinical studies demonstrate that the pneumococcal vaccine can be co-administered safely on the same day as the annual influenza vaccine (gripe) or COVID-19 booster, provided injections are given in different anatomical sites (e.g. opposite arms).
